Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Return on Assets (2016 - 2025)

Abvc Biopharma (ABVC) has disclosed Return on Assets for 12 consecutive years, with 0.36% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 33.0% year-over-year to 0.36%, compared with a TTM value of 0.36% through Dec 2025, up 33.0%, and an annual FY2025 reading of 0.59%, up 15.0% over the prior year.
  • Return on Assets was 0.36% for Q4 2025 at Abvc Biopharma, down from 0.29% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.29% in Q3 2025 and bottomed at 1.63% in Q4 2022.
  • Average Return on Assets over 5 years is 0.93%, with a median of 0.95% recorded in 2021.
  • The sharpest move saw Return on Assets plummeted -70bps in 2022, then surged 96bps in 2025.
  • Year by year, Return on Assets stood at 0.92% in 2021, then plummeted by -76bps to 1.63% in 2022, then skyrocketed by 57bps to 0.7% in 2023, then grew by 2bps to 0.69% in 2024, then surged by 48bps to 0.36% in 2025.
  • Business Quant data shows Return on Assets for ABVC at 0.36% in Q4 2025, 0.29% in Q3 2025, and 0.29% in Q2 2025.